FDA Clearance Tracker · P960009-S483
Activa, Percept and SenSight Deep Brain Stimulation Therapy System
Last checked: Nov 20, 2026Latest source record: Feb 20, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Feb 20, 2025
Approved
Time to decision
245 days
Received Jun 20, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P960009-S483
- Device name
- Activa, Percept and SenSight Deep Brain Stimulation Therapy System
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Jun 20, 2024
- Decided
- Feb 20, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P960009
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
the following: Model A610 Clinician Programmer Application (CPA) version 5.0 Labeling changes in clinician and patient labeling for existing products, to be consistent with the proposed labeling for the Percept system with Model A610 CPA version 5.0
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.